Pascal and Francis Bibliographic Databases


Search results

Your search

kw.\*:("Acide boronique")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 734

  • Page / 30

Selection :

  • and

Use of novel boronic acid transition state inhibitors to probe substrate affinity in SHV-type extended-spectrum β-lactamasesTHOMSON, Jodi M; PRATI, Fabio; BETHEL, Christopher R et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 4, pp 1577-1579, issn 0066-4804, 3 p.Article

Nouvelle synthèse d'aza-carbazoles par association des réactions de métallation et de couplage croisé hétéro-aromatique. Préparation d'alcaloïdes de la famille des bêta-carbolines = New synthesis of aza-carbazoles by association of metalation and hetero-atomic cross-coupling reactions. Preparation of beta-carboline alkaloidsRocca, Patrick; Queguiner, Guy.1992, 220 p.Thesis

Preparation and synthetic application of partially protected brassinosteroidsKHRIPACH, Vladimir A; ZHABINSKII, Vladimir N; ZHIBURTOVICH, Yuliya Y et al.Steroids. 2010, Vol 75, Num 1, pp 27-33, issn 0039-128X, 7 p.Article

Direct observation of a tetrahedral boronic acid-β-lactamase complex using 11B NMR spectroscopyBALDWIN, J. E; CLARIDGE, T. D. W; DEROME, A. E et al.Journal of the Chemical Society. Chemical communications. 1991, Num 8, pp 573-574, issn 0022-4936Article

Novel Insights into the Mode of Inhibition of Class A SHV-1 β-Lactamases Revealed by Boronic Acid Transition State InhibitorsWEI KE; SAMPSON, Jared M; ORI, Claudia et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 1, pp 174-183, issn 0066-4804, 10 p.Article

12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulationYOON MEE YANG; LEE, Sanghwan; CHANG WON NAM et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 7, pp 1230-1237, issn 0143-3334, 8 p.Article

Crystal Structures of KPC-2 β-Lactamase in Complex with 3-Nitrophenyl Boronic Acid and the Penam Sulfone PSR-3-226WEI KE; BETHEL, Christopher R; PAPP-WALLACE, Krisztina M et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 5, pp 2713-2718, issn 0066-4804, 6 p.Article

Novel Proteasome Inhibitors to Overcome Bortezomib ResistanceRUSCHAK, Amy M; SLASSI, Malik; KAY, Lewis E et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 13, pp 1007-1017, issn 0027-8874, 11 p.Article

Interactions of Oximino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42KOTSAKIS, Stathis D; CASELLI, Emilia; TZOUVELEKIS, Leonidas S et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 2, pp 968-976, issn 0066-4804, 9 p.Article

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapyDICK, Lawrence R; FLEMING, Paul E.Drug discovery today. 2010, Vol 15, Num 5-6, pp 243-249, issn 1359-6446, 7 p.Article

Correction: Bortezomib Sensitizes Cells to ER StressCancer research (Chicago, Ill.). 2009, Vol 69, Num 4, issn 0008-5472, p. 1695Article

Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse EventsARASTU-KAPUR, Shirin; ANDERL, Janet L; KIRK, Christopher J et al.Clinical cancer research (Print). 2011, Vol 17, Num 9, pp 2734-2743, issn 1078-0432, 10 p.Article

A new boronic acid based fluorescent reporter for catecholZHONGYU WU; MINYONG LI; HAO FANG et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 23, pp 7179-7182, issn 0960-894X, 4 p.Article

Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment StrategyWRIGHT, John J.Clinical cancer research (Print). 2010, Vol 16, Num 16, pp 4094-4104, issn 1078-0432, 11 p.Article

Can Tumor Growth Be Further Inhibited by Combining Drugs Such as Bortezomib with Image-guided Interventional Oncologic Procedures?NAHUM GOLDBERG, S.Radiology. 2008, Vol 248, Num 2, pp 323-325, issn 0033-8419, 3 p.Article

Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade)ARPINATI, M; CHIRUMBOLO, G; NICOLINI, B et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 3, pp 253-259, issn 0268-3369, 7 p.Article

Carbapénèmases de type KPC: quel enjeu en microbiologie clinique ? = KPC carbapenemases: What issue in clinical microbiology?CUZON, G; NAAS, T; NORDMANN, P et al.Pathologie et biologie. 2010, Vol 58, Num 1, pp 39-45, issn 0369-8114, 7 p.Article

Synthesis and evaluation of boronic acids as inhibitors of Penicillin Binding Proteins of classes A, B and CZERVOSEN, Astrid; BOUILLEZ, Andre; HERMAN, Alexandre et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 12, pp 3915-3924, issn 0968-0896, 10 p.Article

Bortezomib Combination Therapy in Multiple MyelomaKAPOOR, Prashant; RAMAKRISHNAN, Vijay; VINCENT RAJKUMAR, S et al.Seminars in hematology. 2012, Vol 49, Num 3, pp 228-242, issn 0037-1963, 15 p.Article

Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transitionTAMURA, Daisuke; ARAO, Tokuzo; KOTANI, Yoshikazu et al.Cancer science. 2010, Vol 101, Num 6, pp 1403-1408, issn 1347-9032, 6 p.Article

Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compoundsPOURNARAS, Spyros; POULOU, Aggeliki; TSAKRIS, Athanassios et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 7, pp 1319-1321, issn 0305-7453, 3 p.Article

Pralatrexate Is Synergistic with the Proteasome Inhibitor Bortezomib in In vitro and In vivo Models of T-Cell Lymphoid MalignanciesMARCHI, Enrica; PAOLUZZI, Luca; SCOTTO, Luigi et al.Clinical cancer research (Print). 2010, Vol 16, Num 14, pp 3648-3658, issn 1078-0432, 11 p.Article

Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphomaDI BELLA, Nicholas; TAETLE, Raymond; VUKELJA, Svetislava J et al.Blood. 2010, Vol 115, Num 3, pp 475-480, issn 0006-4971, 6 p.Article

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantationKAI SUN; MINGHUI LI; SAYERS, Thomas J et al.Blood. 2008, Vol 112, Num 4, pp 1522-1529, issn 0006-4971, 8 p.Article

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal diseaseWECHALEKAR, Ashutosh D; LACHMANN, Helen J; OFFER, Mark et al.Haematologica (Roma). 2008, Vol 93, Num 2, pp 295-298, issn 0390-6078, 4 p.Article

  • Page / 30